Overview

Evaluate Safety and Pharmacokinetic To Assess Bronchopulmonary Disposition of Intravenous Delafloxacin in Healthy Adults

Status:
Completed
Trial end date:
2018-07-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the steady-state intrapulmonary disposition of delafloxacin in healthy adult participants.
Phase:
Phase 1
Details
Lead Sponsor:
Melinta Therapeutics, Inc.
Treatments:
Fluoroquinolones